FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W32840760> ?p ?o ?g. }

• W32840760 endingPage "32" @default.
• W32840760 startingPage "23" @default.
• W32840760 abstract "Chemotherapy trials were run with mice bearing transplants of carcinomas originally induced from fetal mouse lung cells by asbestos. After treatments with a nitrosourea (PCNU), mice bearing transplants of a large-cell carcinoma (ASB XIV) had complete remissions (CR) in 13 of 20 animals on a 15 mg/kg regimen, in 6 of 20 on an 8 mg/kg regimen, and in none of 10 on a 4 mg/kg regimen. With comparable total doses, treatment was most effective when PCNU was given in a few large doses. In groups where CRs occurred, continued PCNU treatment of animals without CRs prolonged survival but yielded no additional CRs. No CRs of ASB XIV occurred in 80 mice treated with eight other anticancer agents or in 50 controls injected with 0.9% NaCl solution. In mice bearing transplants of a squamous cell carcinoma (ASB XIII), treatments with PCNU were followed by CRs in 3 of 38 animals on 15 mg/kg regimens and in 3 of 28 animals on 8 mg/kg regimens. In groups of 6 mice fed a retinoid (Ro 10-9359) and treated with PCNU, CRs of ASB XIII occurred in 3 animals in each of two trials and in none in a third trial. Ro 10-9359 inhibited growth of transplants of squamous cell carcinoma LC 12 that had been induced from fetal mouse lung cells by a polycyclic hydrocarbon. In trials of four other anticancer agents vs. ASB XIII, CRs occurred only with cyclophosphamide (CPA). There were 7 CRs among 8 mice treated with CPA 100 mg/kg x 3, no CRs in 10 after 100 mg/kg x 2, one CR in 8 after 50 mg/kg x 3, and no CRs in 6 after 50 mg/kg x 4. With the 50 mg/kg x 4 regimen of CPA and 7.5 mg/kg PCNU on the same days, there were 5 CRs in 8 mice. As a single agent, aziridinylbenzoquinone (AZQ) increased life span but gave no CRs. There were CRs of ASB XIII in all of 8 mice after toxic combined therapy with PCNU and AZQ. There were no CRs in 66 control mice bearing ASB XIII." @default.
• W32840760 created "2016-06-24" @default.
• W32840760 creator A5002516367 @default.
• W32840760 creator A5012225982 @default.
• W32840760 creator A5022055253 @default.
• W32840760 creator A5032106258 @default.
• W32840760 creator A5036253828 @default.
• W32840760 creator A5037898824 @default.
• W32840760 creator A5046663562 @default.
• W32840760 creator A5074816714 @default.
• W32840760 date "2005-01-01" @default.
• W32840760 modified "2023-09-26" @default.
• W32840760 title "Complete remissions in chemotherapy of lung cancer models induced in mice by asbestos." @default.
• W32840760 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15682259" @default.
• W32840760 hasPublicationYear "2005" @default.
• W32840760 type Work @default.
• W32840760 sameAs 32840760 @default.
• W32840760 citedByCount "0" @default.
• W32840760 crossrefType "journal-article" @default.
• W32840760 hasAuthorship W32840760A5002516367 @default.
• W32840760 hasAuthorship W32840760A5012225982 @default.
• W32840760 hasAuthorship W32840760A5022055253 @default.
• W32840760 hasAuthorship W32840760A5032106258 @default.
• W32840760 hasAuthorship W32840760A5036253828 @default.
• W32840760 hasAuthorship W32840760A5037898824 @default.
• W32840760 hasAuthorship W32840760A5046663562 @default.
• W32840760 hasAuthorship W32840760A5074816714 @default.
• W32840760 hasConcept C126322002 @default.
• W32840760 hasConcept C143998085 @default.
• W32840760 hasConcept C203014093 @default.
• W32840760 hasConcept C2776256026 @default.
• W32840760 hasConcept C2776694085 @default.
• W32840760 hasConcept C2776755627 @default.
• W32840760 hasConcept C2777546739 @default.
• W32840760 hasConcept C2777714996 @default.
• W32840760 hasConcept C2778670039 @default.
• W32840760 hasConcept C2781413609 @default.
• W32840760 hasConcept C71924100 @default.
• W32840760 hasConcept C90924648 @default.
• W32840760 hasConcept C98274493 @default.
• W32840760 hasConceptScore W32840760C126322002 @default.
• W32840760 hasConceptScore W32840760C143998085 @default.
• W32840760 hasConceptScore W32840760C203014093 @default.
• W32840760 hasConceptScore W32840760C2776256026 @default.
• W32840760 hasConceptScore W32840760C2776694085 @default.
• W32840760 hasConceptScore W32840760C2776755627 @default.
• W32840760 hasConceptScore W32840760C2777546739 @default.
• W32840760 hasConceptScore W32840760C2777714996 @default.
• W32840760 hasConceptScore W32840760C2778670039 @default.
• W32840760 hasConceptScore W32840760C2781413609 @default.
• W32840760 hasConceptScore W32840760C71924100 @default.
• W32840760 hasConceptScore W32840760C90924648 @default.
• W32840760 hasConceptScore W32840760C98274493 @default.
• W32840760 hasIssue "1" @default.
• W32840760 hasLocation W328407601 @default.
• W32840760 hasOpenAccess W32840760 @default.
• W32840760 hasPrimaryLocation W328407601 @default.
• W32840760 hasRelatedWork W1509107424 @default.
• W32840760 hasRelatedWork W1977413886 @default.
• W32840760 hasRelatedWork W1978059264 @default.
• W32840760 hasRelatedWork W1978730328 @default.
• W32840760 hasRelatedWork W2089711546 @default.
• W32840760 hasRelatedWork W2325954033 @default.
• W32840760 hasRelatedWork W2355942484 @default.
• W32840760 hasRelatedWork W2378355431 @default.
• W32840760 hasRelatedWork W2402070405 @default.
• W32840760 hasRelatedWork W2474037415 @default.
• W32840760 hasVolume "72" @default.
• W32840760 isParatext "false" @default.
• W32840760 isRetracted "false" @default.
• W32840760 magId "32840760" @default.
• W32840760 workType "article" @default.